BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18701655)

  • 21. Mucosa-associated Faecalibacterium prausnitzii phylotype richness is reduced in patients with inflammatory bowel disease.
    Lopez-Siles M; Martinez-Medina M; Abellà C; Busquets D; Sabat-Mir M; Duncan SH; Aldeguer X; Flint HJ; Garcia-Gil LJ
    Appl Environ Microbiol; 2015 Nov; 81(21):7582-92. PubMed ID: 26296733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diversity of the human intestinal microbial flora.
    Eckburg PB; Bik EM; Bernstein CN; Purdom E; Dethlefsen L; Sargent M; Gill SR; Nelson KE; Relman DA
    Science; 2005 Jun; 308(5728):1635-8. PubMed ID: 15831718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A diet based on cured acorn-fed ham with oleic acid content promotes anti-inflammatory gut microbiota and prevents ulcerative colitis in an animal model.
    Fernández J; de la Fuente VG; García MTF; Sánchez JG; Redondo BI; Villar CJ; Lombó F
    Lipids Health Dis; 2020 Feb; 19(1):28. PubMed ID: 32093685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muc5ac Expression Protects the Colonic Barrier in Experimental Colitis.
    Olli KE; Rapp C; O'Connell L; Collins CB; McNamee EN; Jensen O; Jedlicka P; Allison KC; Goldberg MS; Gerich ME; Frank DN; Ir D; Robertson CE; Evans CM; Aherne CM
    Inflamm Bowel Dis; 2020 Aug; 26(9):1353-1367. PubMed ID: 32385500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diversity of the autochthonous colonic microbiota.
    Nava GM; Stappenbeck TS
    Gut Microbes; 2011; 2(2):99-104. PubMed ID: 21694499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid.
    Kabeerdoss J; Jayakanthan P; Pugazhendhi S; Ramakrishna BS
    Indian J Med Res; 2015 Jul; 142(1):23-32. PubMed ID: 26261163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial effects resulting from oral administration of
    Souza ELS; Campos CLV; Reis DC; Cassali GD; Generoso SV; Cardoso VN; Azevedo V; Medeiros JD; Fernandes GR; Nicoli JR; Martins FS
    Benef Microbes; 2020 Dec; 11(8):779-790. PubMed ID: 33191778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The rectal mucosa-associated microflora in patients with ulcerative colitis.
    Hartley MG; Hudson MJ; Swarbrick ET; Hill MJ; Gent AE; Hellier MD; Grace RH
    J Med Microbiol; 1992 Feb; 36(2):96-103. PubMed ID: 1740790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlations between colonic crypt mucin chemotype, inflammatory grade and Desulfovibrio species in ulcerative colitis.
    Lennon G; Balfe Á; Bambury N; Lavelle A; Maguire A; Docherty NG; Coffey JC; Winter DC; Sheahan K; O'Connell PR
    Colorectal Dis; 2014 May; 16(5):O161-9. PubMed ID: 24345279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis.
    Sokol H; Lepage P; Seksik P; Doré J; Marteau P
    J Clin Microbiol; 2006 Sep; 44(9):3172-7. PubMed ID: 16954244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sulphasalazine treatment and the colorectal mucosa-associated flora in ulcerative colitis.
    Hartley MG; Hudson MJ; Swarbrick ET; Grace RH; Gent AE; Hellier MD
    Aliment Pharmacol Ther; 1996 Apr; 10(2):157-63. PubMed ID: 8730244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.
    Ma HQ; Yu TT; Zhao XJ; Zhang Y; Zhang HJ
    World J Gastroenterol; 2018 Apr; 24(13):1464-1477. PubMed ID: 29632427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis.
    Lepage P; Häsler R; Spehlmann ME; Rehman A; Zvirbliene A; Begun A; Ott S; Kupcinskas L; Doré J; Raedler A; Schreiber S
    Gastroenterology; 2011 Jul; 141(1):227-36. PubMed ID: 21621540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced Mucosa-associated Butyricicoccus Activity in Patients with Ulcerative Colitis Correlates with Aberrant Claudin-1 Expression.
    Devriese S; Eeckhaut V; Geirnaert A; Van den Bossche L; Hindryckx P; Van de Wiele T; Van Immerseel F; Ducatelle R; De Vos M; Laukens D
    J Crohns Colitis; 2017 Feb; 11(2):229-236. PubMed ID: 27484096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gram-negative bacteria account for main differences between faecal microbiota from patients with ulcerative colitis and healthy controls.
    Vigsnæs LK; Brynskov J; Steenholdt C; Wilcks A; Licht TR
    Benef Microbes; 2012 Dec; 3(4):287-97. PubMed ID: 22968374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moxibustion treatment modulates the gut microbiota and immune function in a dextran sulphate sodium-induced colitis rat model.
    Qi Q; Liu YN; Jin XM; Zhang LS; Wang C; Bao CH; Liu HR; Wu HG; Wang XM
    World J Gastroenterol; 2018 Jul; 24(28):3130-3144. PubMed ID: 30065559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis.
    Yoshimatsu Y; Yamada A; Furukawa R; Sono K; Osamura A; Nakamura K; Aoki H; Tsuda Y; Hosoe N; Takada N; Suzuki Y
    World J Gastroenterol; 2015 May; 21(19):5985-94. PubMed ID: 26019464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat.
    Fabia R; Ar'Rajab A; Johansson ML; Andersson R; Willén R; Jeppsson B; Molin G; Bengmark S
    Digestion; 1993; 54(4):248-55. PubMed ID: 8243838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls.
    Kleessen B; Kroesen AJ; Buhr HJ; Blaut M
    Scand J Gastroenterol; 2002 Sep; 37(9):1034-41. PubMed ID: 12374228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-13 mRNA Tissue Content Identifies Two Subsets of Adult Ulcerative Colitis Patients With Different Clinical and Mucosa-Associated Microbiota Profiles.
    Butera A; Di Paola M; Vitali F; De Nitto D; Covotta F; Borrini F; Pica R; De Filippo C; Cavalieri D; Giuliani A; Pronio A; Boirivant M
    J Crohns Colitis; 2020 Mar; 14(3):369-380. PubMed ID: 31501882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.